Acute pancreatitis after ocrelizumab treatment for relapsing remitting multiple sclerosis

被引：4

作者：

Adamec, Ivan ^{[1
]}

Reiner, Zeljko ^{[2
,3
]}

Pecin, Ivan ^{[2
,3
]}

Sucur, Nediljko ^{[2
]}

Hauptman, Ana Godan ^{[2
]}

Barun, Barbara ^{[1
,3
]}

Gabelic, Tereza ^{[1
,3
]}

Habek, Mario ^{[1
,3
]}

机构：

[1] Univ Hosp Ctr Zagreb, Dept Neurol, Referral Ctr Auton Nervous Syst Disorders, Zagreb, Croatia

[2] Univ Hosp Ctr Zagreb, Div Metab Dis, Dept Internal Med, Zagreb, Croatia

[3] Univ Zagreb, Sch Med, Zagreb, Croatia

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 45卷

关键词：

Multiple sclerosis; Ocrelizumab; Pancreatitis;

D O I：

10.1016/j.msard.2020.102381

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Ocrelizumab is an anti-CD20 monoclonal antibody used in the treatment of relapsing remitting and primary progressive multiple sclerosis. The main side effects are infusion-related with long term administration raising the risk of infections. During randomized controlled trials five cases of pancreatitis have been reported. We present a case of a patient with no risk factors for pancreatitis who after administration developed acute pancreatitis albeit with a good recovery.

引用

页数：2

共 7 条

[1]

[Anonymous], 2015, CTR DRUG EV RES

[2] Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus [J].

Banks, Peter A. ;

Bollen, Thomas L. ;

Dervenis, Christos ;

Gooszen, Hein G. ;

Johnson, Colin D. ;

Sarr, Michael G. ;

Tsiotos, Gregory G. ;

Vege, Santhi Swaroop .

GUT, 2013, 62 (01) :102-111

[3]

Jones MR, 2015, OCHSNER J, V15, P45

[4] Ocrelizumab: its efficacy and safety in multiple sclerosis [J].

Juanatey, Ana ;

Blanco-Garcia, Laura ;

Tellez, Nieves .

REVISTA DE NEUROLOGIA, 2018, 66 (12) :423-433

[5] Regulatory role of mature B cells in a murine model of inflammatory bowel disease [J].

Mizoguchi, E ;

Mizoguchi, A ;

Preffer, FI ;

Bhan, AK .

INTERNATIONAL IMMUNOLOGY, 2000, 12 (05) :597-605

[6]

Sunjaya DB., 2020, Inflamm Bowel Dis, V26

[7]

UNDERWOOD TW, 1993, CLIN PHARMACY, V12, P440

← 1 →